K.W. Bock
Impact in
- Pharmacology top 0.5%
- Pharmacogenetics and Drug Metabolism
- Cancer Research top 10%
- Carcinogens and Genotoxicity Assessment
Papers in
-
- Pharmacogenetics and Drug Metabolism 5
- Biological Stains and Phytochemicals 1
- Oncology 6
- Cancer-related Molecular Pathways 4
- Co-authors
- Peter I. Mackenzie (1 shared paper)Jayanta Roy Chowdhury (1 shared paper)Amos Bairoch (1 shared paper)Brian Burchell (1 shared paper)Jacques Magdalou (1 shared paper)Keith Francis Tipton (1 shared paper)Harry Schachter (1 shared paper)Doron Lancet (1 shared paper)
- Journals
- Carcinogenesis (2 papers)Toxicology Letters (2 papers)Toxicology and Applied Pharmacology (1 paper)European Journal of Clinical Pharmacology (1 paper)Journal of Cancer Research and Clinical Oncology (1 paper)
- Partner nations
- GermanyUnited StatesFrance
In The Last Decade
K.W. Bock
14 papers receiving 1.3k citations
K.W. Bock's Hit Papers
Peers
Comparison fields: 5 of 96
- Pharmacology 475
- Cancer Research 172
- Pediatrics, Perinatology and Child Health 213
- Oncology 280
- Health, Toxicology and Mutagenesis 154
Countries citing papers authored by K.W. Bock
This map shows the geographic impact of K.W. Bock's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K.W. Bock with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K.W. Bock more than expected).
Fields of papers citing papers by K.W. Bock
This network shows the impact of papers produced by K.W. Bock. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K.W. Bock. The network helps show where K.W. Bock may publish in the future.
Co-authors
The 25 scholars most cited alongside K.W. Bock, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | The UDP glycosyltransferase gene superfamily: recommended nomenclature update based on evolutionary divergence Hit paper breakdown → | 1997 | 1037 |
| 2 | 2000 | 58 | |
| 3 | 1995 | 51 | |
| 4 | 1995 | 39 | |
| 5 | 1993 | 35 | |
| 6 | 1991 | 35 | |
| 7 | 1996 | 30 | |
| 8 | 1974 | 26 | |
| 9 | 2002 | 20 | |
| 10 | 1995 | 18 | |
| 11 | 1989 | 7 | |
| 12 | 1990 | 6 | |
| 13 | 1978 | 5 | |
| 14 | 1974 | 2 |
About K.W. Bock
K.W. Bock is a scholar working on Pharmacology, Oncology, Cancer Research, Health, Toxicology and Mutagenesis and Molecular Biology, having authored 14 papers that have together received 1.4k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (5 papers), Cancer-related Molecular Pathways (4 papers), Carcinogens and Genotoxicity Assessment (3 papers), Glycosylation and Glycoproteins Research (2 papers), Toxic Organic Pollutants Impact (2 papers), Complementary and Alternative Medicine Studies (1 paper), Biological Stains and Phytochemicals (1 paper) and RNA modifications and cancer (1 paper). The work is most often cited by research in Pharmacology (475 citations), Cancer Research (172 citations), Pediatrics, Perinatology and Child Health (213 citations), Oncology (280 citations) and Health, Toxicology and Mutagenesis (154 citations). K.W. Bock has collaborated with scholars based in Germany, United States and France. Frequent co-authors include Peter I. Mackenzie, Jayanta Roy Chowdhury, Amos Bairoch, Brian Burchell, Jacques Magdalou, Keith Francis Tipton, Harry Schachter, Doron Lancet, Alain Bélanger and Ida S. Owens. Their work appears in journals such as Carcinogenesis, Toxicology Letters, Toxicology and Applied Pharmacology, European Journal of Clinical Pharmacology and Journal of Cancer Research and Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.